Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature

Table 1 Laboratory examination in cases 1 and 2

Laboratory examination
White blood cells	8100/μL	4200/μL
Hb	15.6 g/dL	15.1 g/dL
Ht	45.90%	43.50%
MCV	96.2 fl	94.2 fl
PLT	162000/μL	141000/μL
PT-INR	0.96	1
PT%	107%	100.50%
T-BIL	0.6 mg/dL	1.3 mg/dL
AST	62 U/L	18 U/L
ALT	60 U/L	14 U/L
γGTP	689 U/L	68 U/L
ALP	423 U/L	249 U/L
TP	8 g/dL	7.1 g/dL
ALB	3.8 g/dL	4 g/dL
HbA1c	7.10%	5.50%
BUN	16.4 mg/dL	21.7 mg/dL
CRE	0.68 mg/dL	1.05 mg/dL
CRP	0.524 mg/dL	0.149 mg/dL
AFP	276.8 ng/mL	3.6 ng/mL
PIVKA-II	33224 mAU/mL	44 mAU/mL
CEA	5.9 ng/mL	4.5 ng/mL
HBs antigens	(-)	(-)
HBc antibody	(-)	(+)
HCV antibody	(-)	(-)

AFP: Alpha-fetoprotein; PIVKA: Protein induced by vitamin K antagonists; TP: Total protein; Alb: Albumin; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Cr: Creatinine; CRP: C-reactive protein; Hb: Hemoglobin; PLT: Platelet count; PT: Prothrombin time; PT-INR: International normalized ratio of prothrombin time; T-BIL: Total bilirubin; WBC: White blood cells; HBc: Antibody hepatitis B core antibody; HBs: Antigen hepatitis B surface antigen; HCV: Antibody hepatitis C virus antibody.